PLOS One editors issued a concise Editorial Note regarding the 2025 research article titled “Naringenin impairs mitochondrial function via ROS to induce apoptosis in tamoxifen resistant MCF-7 breast cancer cells.” The note identifies two bibliographic items cited in that article that carry retraction status: one (Reference 23) was retracted after the article’s publication, and another (Reference 52) had been retracted before the article appeared online. The editorial text does not reproduce the content of those retracted sources.
Short and factual. That describes the core of the notice.
The editors made a temporal distinction: Reference 52 had already been retracted at the time the 2025 article was published, while Reference 23 was retracted subsequently. The Editorial Note reports that PLOS judged these two retracted works to be nonessential to the research claims and conclusions presented in the article. The journal did not offer any further corrections to the article’s data, figures, or conclusions within this Note.
This is an editorial clarification rather than a correction. The editors reported their assessment and left the original article record intact.
The Editorial Note cites the original research article as authored by Eanes LA, Eldeeb M, Storholt D, Patel YM and gives the PLoS One citation details as recorded in the journal’s reference section. The Research Article appears in PLoS One (2025) with the identifier cited by the editors; the Editorial Note itself was published November 17, 2026, and carries its own DOI as a CrossRef record. The editorial record links directly to the original article page, the downloadable PDF, PubMed/NCBI record, and Google Scholar entry where readers can review the article’s full text and reference list.
The editors explicitly stated that the two retracted references are not crucial for supporting the research or conclusions in the 2025 article. The Note does not present new experimental evidence, nor does it list methodological corrections. The study’s title—referring to Naringenin, ROS, and tamoxifen resistant MCF-7 cells—remains unchanged in the journal record as presented in the Editorial Note.
Readers should understand that an Editorial Note with this scope serves to inform the audience about the status of cited literature and the editorial judgment that those citations do not invalidate the article’s reported findings. The Note does not equate to a retraction, expression of concern, or formal correction to the original work.
The editors provided direct links to the original article page and its associated resources: the article HTML, the printable PDF, citation metadata, and the PubMed/NCBI entry referenced in the journal record. The Editorial Note also points to the article metrics and the comments section on the PLOS One platform for readers who wish to examine postpublication discussion. The Note lists the original article in the reference section for clarity.
Follow the journal links if you need to inspect the article’s full reference list or to confirm the current status of any cited item.
PLOS published the Editorial Note under an open-access Creative Commons Attribution license. The Note carries the journal’s citation block and a CrossRef DOI, and it is presented as a formal editorial record in the PLOS One issue list. The editors’ statement completes with the assertion that, following their assessment, no further editorial action was required because the retracted references were judged not to be essential to the study’s conclusions.
Limitations and outstanding items: the Editorial Note does not supply details about the content or authorship of the retracted references, and it does not include corrections to the original article’s experimental data or conclusions. For readers seeking additional context—such as the reasons for the cited retractions, whether those retractions affect specific passages in the text, or any subsequent author responses—PLOS directs readers to the linked original article page, the retraction notices for the cited references where available, and the platform comment threads. The Editorial Note itself stops at documenting the retraction status and the editors’ judgment; it does not advance further editorial measures in the record.